ESR1 and prostate carcinoma: To evaluate this further and to determine whether a functional synergy between ERα and NEAT1 pathways exists in prostate cancer cells, we performed RNA-seq of vector control and NEAT1-overexpressing VCaP cells to determine a NEAT1 signature.